Loading...
Collection title
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Last deposits
-
C. Plainvert, E. Varon, D. Viriot, M. Kempf, C. Plainvert, et al.. Invasive pneumococcal infections in France: Changes from 2009 to 2021 in antibiotic resistance and serotype distribution of Streptococcus pneumoniae based on data from the French Regional Pneumococcal Observatories network. Infectious Diseases Now, 2023, 53 (1), pp.104632. ⟨10.1016/j.idnow.2022.11.001⟩. ⟨hal-03992594⟩
-
Lydie Masson, Laure Barbé, Fanny Henaff, Tasnuva Ahmed, Béatrice Le Moullac-Vaidye, et al.. Extent of the protection afforded by histo-blood group polymorphism against rotavirus gastroenteritis in metropolitan France and French Guiana. Frontiers in Microbiology, 2023, 14, pp.1141652. ⟨10.3389/fmicb.2023.1141652⟩. ⟨inserm-04047907⟩
-
Frédéric Jaouen, Thibault Kervarrec, Agnès Caille, Yannick Le Corre, Brigitte Dreno, et al.. Narrow resection margins are not associated with mortality or recurrence in patients with Merkel cell carcinoma: a retrospective study. Journal of The American Academy of Dermatology, 2021, 84 (4), pp.921-929. ⟨10.1016/j.jaad.2020.11.038⟩. ⟨hal-03151003⟩
-
-
Paolo Antonio Ascierto, Evan Lipson, Reinhard Dummer, James Larkin, Georgina Long, et al.. Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial. Journal of Clinical Oncology, 2023, Online ahead of print. ⟨10.1200/JCO.22.02072⟩. ⟨inserm-03996644⟩